CASI Pharmaceuticals (CASIF) Gross Margin (2022 - 2025)
CASI Pharmaceuticals (CASIF) recorded Gross Margin of 51.14% in Q4 2025, up 26.97 percentage points from 24.17% a year earlier and up 28.18 percentage points from the prior quarter.
Powered by 
Analysis
CASI Pharmaceuticals (CASIF) Gross Margin (2022 - 2025) Analysis & Trends
For FY2025, CASI Pharmaceuticals reported Gross Margin of 48.65%, up 9.59 percentage points from FY2024.
- Annual Gross Margin has a five-year change of +11.44 percentage points (FY2020 to FY2025).
- Across earlier years, Gross Margin came in at 39.06% in FY2024 (-20.13 pp), 59.19% in FY2023 (-4.10 pp), 63.28% in FY2022 (+4.91 pp) and 58.38% in FY2021 (+21.17 pp).
- Quarterly Gross Margin has ranged from 22.96% in Q3 2025 to 71.72% in Q4 2022 over the past five years.
- On a year-over-year basis, Gross Margin rose in two of the last eight quarters, with an average year-over-year change of -6.92 percentage points.
- Peak year-over-year performance for Gross Margin in the last five years was a gain of 26.97 percentage points in Q4 2025, against a drop of 34.88 percentage points in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at 22.96% (Q3 2025), 49.29% (Q2 2025) and 58.00% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.03% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 75.71% |
| 10 | CASI Pharmaceuticals | 2.06 Mn | -18.77 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 51.14% |
| Sep 30, 2025 | 22.96% |
| Jun 30, 2025 | 49.29% |
| Mar 31, 2025 | 58.00% |
| Dec 31, 2024 | 24.17% |
| Sep 30, 2024 | 51.91% |
| Jun 30, 2024 | 51.95% |
| Mar 31, 2024 | 52.98% |
| Dec 31, 2023 | 59.05% |
| Sep 30, 2023 | 58.72% |
| Jun 30, 2023 | 59.41% |
| Mar 31, 2023 | 59.53% |
| Dec 31, 2022 | 72.00% |
| Sep 30, 2022 | 58.42% |
| Jun 30, 2022 | 58.59% |
| Mar 31, 2022 | 58.53% |
API Access
CASI Pharmaceuticals Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=CASIF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "CASIF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=CASIF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();